The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challenges

Juliet M. Foster, Thys van der Molen, Manfred Caeser, Philip Hannaford

Research output: Contribution to journalLiterature review

30 Citations (Scopus)

Abstract

Patient-reported outcomes such as Quality of Life often play an important part in the efficacy assessment of drug treatment. Although instruments that measure quality of life can detect the positive effects of treatments on health status, they may not measure the effect of negative treatment-related symptoms. Patients often fail to spontaneously report common or clinically mild drug-related symptoms, even though the same symptoms can result in the stopping or skipping of prescribed doses. Therefore, as with quality of life assessments, the perception of patients on possible side effects of treatments is best captured by the use of self-report questionnaires. There are substantial challenges with creating well-validated, relevant questionnaires that capture the full range of patient-reported symptoms and signs. A review of 13 existing instruments showed that many patient-rated side effect questionnaires had been developed, often to a high standard, using well-established psychometric methods. However, there were some inconsistencies in the methods used by the questionnaire developers, indicating the need for standardisation when creating new, or adapting previous, instruments. Even with their current deficits, it is important that patient-reported side effect questionnaires be used more in drug development, health outcomes research and resource allocation; all with the ultimate aim of improving quality of patient care. Copyright (c) 2008 John Wiley & Sons, Ltd.

Original languageEnglish
Pages (from-to)278-296
Number of pages19
JournalPharmacoepidemiology and Drug Safety
Volume17
Issue number3
Early online date25 Feb 2008
DOIs
Publication statusPublished - Mar 2008

Keywords

  • side effects
  • questionnaires
  • survey methods
  • patient outcome assessment
  • quality-of-life
  • self-rating scale
  • pylori eradication therapy
  • assessment schedule ABNAS
  • inhaled corticosteroids
  • psychometric evaluation
  • breast-cancer
  • assessing neurotoxicity
  • peripheral neuropathy
  • patients experiences

Cite this

The use of questionnaires for measuring patient-reported side effects of drugs : its importance and methodological challenges. / Foster, Juliet M.; van der Molen, Thys; Caeser, Manfred; Hannaford, Philip.

In: Pharmacoepidemiology and Drug Safety, Vol. 17, No. 3, 03.2008, p. 278-296.

Research output: Contribution to journalLiterature review

@article{d2b167cfc3d84896a49a6b238097e6d8,
title = "The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challenges",
abstract = "Patient-reported outcomes such as Quality of Life often play an important part in the efficacy assessment of drug treatment. Although instruments that measure quality of life can detect the positive effects of treatments on health status, they may not measure the effect of negative treatment-related symptoms. Patients often fail to spontaneously report common or clinically mild drug-related symptoms, even though the same symptoms can result in the stopping or skipping of prescribed doses. Therefore, as with quality of life assessments, the perception of patients on possible side effects of treatments is best captured by the use of self-report questionnaires. There are substantial challenges with creating well-validated, relevant questionnaires that capture the full range of patient-reported symptoms and signs. A review of 13 existing instruments showed that many patient-rated side effect questionnaires had been developed, often to a high standard, using well-established psychometric methods. However, there were some inconsistencies in the methods used by the questionnaire developers, indicating the need for standardisation when creating new, or adapting previous, instruments. Even with their current deficits, it is important that patient-reported side effect questionnaires be used more in drug development, health outcomes research and resource allocation; all with the ultimate aim of improving quality of patient care. Copyright (c) 2008 John Wiley & Sons, Ltd.",
keywords = "side effects, questionnaires, survey methods, patient outcome assessment, quality-of-life, self-rating scale, pylori eradication therapy, assessment schedule ABNAS, inhaled corticosteroids, psychometric evaluation, breast-cancer, assessing neurotoxicity, peripheral neuropathy, patients experiences",
author = "Foster, {Juliet M.} and {van der Molen}, Thys and Manfred Caeser and Philip Hannaford",
year = "2008",
month = "3",
doi = "10.1002/pds.1533",
language = "English",
volume = "17",
pages = "278--296",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - The use of questionnaires for measuring patient-reported side effects of drugs

T2 - its importance and methodological challenges

AU - Foster, Juliet M.

AU - van der Molen, Thys

AU - Caeser, Manfred

AU - Hannaford, Philip

PY - 2008/3

Y1 - 2008/3

N2 - Patient-reported outcomes such as Quality of Life often play an important part in the efficacy assessment of drug treatment. Although instruments that measure quality of life can detect the positive effects of treatments on health status, they may not measure the effect of negative treatment-related symptoms. Patients often fail to spontaneously report common or clinically mild drug-related symptoms, even though the same symptoms can result in the stopping or skipping of prescribed doses. Therefore, as with quality of life assessments, the perception of patients on possible side effects of treatments is best captured by the use of self-report questionnaires. There are substantial challenges with creating well-validated, relevant questionnaires that capture the full range of patient-reported symptoms and signs. A review of 13 existing instruments showed that many patient-rated side effect questionnaires had been developed, often to a high standard, using well-established psychometric methods. However, there were some inconsistencies in the methods used by the questionnaire developers, indicating the need for standardisation when creating new, or adapting previous, instruments. Even with their current deficits, it is important that patient-reported side effect questionnaires be used more in drug development, health outcomes research and resource allocation; all with the ultimate aim of improving quality of patient care. Copyright (c) 2008 John Wiley & Sons, Ltd.

AB - Patient-reported outcomes such as Quality of Life often play an important part in the efficacy assessment of drug treatment. Although instruments that measure quality of life can detect the positive effects of treatments on health status, they may not measure the effect of negative treatment-related symptoms. Patients often fail to spontaneously report common or clinically mild drug-related symptoms, even though the same symptoms can result in the stopping or skipping of prescribed doses. Therefore, as with quality of life assessments, the perception of patients on possible side effects of treatments is best captured by the use of self-report questionnaires. There are substantial challenges with creating well-validated, relevant questionnaires that capture the full range of patient-reported symptoms and signs. A review of 13 existing instruments showed that many patient-rated side effect questionnaires had been developed, often to a high standard, using well-established psychometric methods. However, there were some inconsistencies in the methods used by the questionnaire developers, indicating the need for standardisation when creating new, or adapting previous, instruments. Even with their current deficits, it is important that patient-reported side effect questionnaires be used more in drug development, health outcomes research and resource allocation; all with the ultimate aim of improving quality of patient care. Copyright (c) 2008 John Wiley & Sons, Ltd.

KW - side effects

KW - questionnaires

KW - survey methods

KW - patient outcome assessment

KW - quality-of-life

KW - self-rating scale

KW - pylori eradication therapy

KW - assessment schedule ABNAS

KW - inhaled corticosteroids

KW - psychometric evaluation

KW - breast-cancer

KW - assessing neurotoxicity

KW - peripheral neuropathy

KW - patients experiences

U2 - 10.1002/pds.1533

DO - 10.1002/pds.1533

M3 - Literature review

VL - 17

SP - 278

EP - 296

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 3

ER -